___

• André, F. E. (2003). Vaccinology: past achievements, present roadblocks and future promises. Vaccine, 21, 593–595.
• Arda, M. & Sareyyüpoğlu, B. (2004). Aşılar; Hazırlama Teknikleri, Avantaj ve Dezavantajları. Ankara, Turkey: İnkansa Yayınları.
• Basavarajappa, M. K., Kumar, S., Khattar, S. K., Gebreluul, G. T., Paldurai, A. & Samal, S. K. (2014). A recombinant Newcastle disease virus (NDV) expressing infectiouslaryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens. Vaccine, 32, 3555-3563.
• Bouazzaoui, A., Abdellatif, A. A. H., Al-Allaf, F. A., Bogari, N. M., Al-Dehlawi, S. & Qari, S. H. (2021). Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants. Pharmaceutics, 13, 140.
• Bublot, M., Pritchard, N., Le Gros, F. X. & Goutebroze, S. (2007). Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody. J Comp Pathol, 137, S81–S84.
• Bublot, M., Pritchard, N., Swayne, D. E., Selleck, P., Karaca, K., Suarez, D. L., Audonnet, J. C. & Mickle, T. R. (2006). Development and use of fowlpox vectored vaccines for avian influenza. Ann N Y Acad Sci, 1081,193-201.
• Büyüktanır, Ö. (2010). Günümüzde Biyoteknolojik Bakteriyel Aşılar. Atatürk Üniversitesi Vet Bil Derg, 5, 97-105.
• Choi, K. S. (2017). Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines. Clin Exp Vaccine Res, 6, 72-82.
• El Khantour, A., Darkaoui, S., Tatár-Kis, T., Mató, T., Essalah-Bennani, A., Cazaban, C. & Palya, V. (2017). Immunity Elicited by a Turkey Herpesvirus-Vectored Newcastle Disease Vaccine in Turkey Against Challenge With a Recent Genotype IV Newcastle Disease Virus Field Strain. Avian Dis, 61, 378-386.
• Esaki, M., Noland, L., Eddins, T., Godoy, A., Saeki, S., Saitoh, S., Yasuda, A. & Dorsey, K. M. (2013). Safety and Efficacy of a Turkey Herpesvirus Vector Laryngotracheitis Vaccine for Chickens. Avian Dis, 57, 192-198.
• Gergen, L., Cook, S., Ledesma, B., Cress, W., Higuchi, D., Counts, D., Cruz-Coy, J., Crouch, C., Davis, P., Tarpey, I. & Morsey, M. (2019). A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek’s diseases. Avian Pathol, 48, 45–56.
• Gimeno, I. M., Cortes, A. L., Guy, J. S., Turpin, E. & Williams, C. (2011). Replication of recombinant herpesvirus of turkey expressing genes of infectious laryngotracheitis virus in specific pathogen free and broiler chickens following in ovo and subcutaneous vaccination. Avian Pathol, 40, 395-403.
• Halbherr, S. J., Brostoff, T., Tippenhauer, M., Locher, S., Berger Rentsch, M. & Zimmer, G. (2013). Vaccination with Recombinant RNA Replicon Particles Protects Chickens from H5N1 Highly Pathogenic Avian Influenza Virus. PLoS One, 8, e66059.
• Hanley, K. A. (2011). The double-edged sword: How evolution can make or break a live-attenuated virus vaccine. Evolution (N Y), 4, 635–643.
• Hargis, B. M., Layton, S. L., Kapczynski, D. R., Cole, K., Cox, M. M., Ywon, Y. M., Bergham, L.R., Liljebjelke, K.A. & Bottje, W. J. (2008). Development and evaluation of a potential universal Salmonella-vectored avian influenza vaccine. Poultry Science Association Annual Meeting, Niagara Falls, Canada, 2008, 2-3.
• Heckert, R. A., Riva, J., Cook, S., Mcmillen, J. & Schwartz, R. D. (1996). Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens. Avian Dis, 40, 770-777.
• Hein, R., Koopman, R., García, M., Armour, N., Dunn, J. R., Barbosa, T. & Martinez, A. (2021). Review of Poultry Recombinant Vector Vaccines. Avian Dis, 65, 438–452.
• Hu, Z., Ni, J., Cao, Y. & Liu, X. (2020). Newcastle Disease Virus as a Vaccine Vector for 20 Years: A Focus on Maternally Derived Antibody Interference. Vaccines, 8, 222.
• Huang, Z., Elankumaran, S., Yunus, A. S. & Samal, S. K. (2004). A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J Virol, 78, 10054-10063.
• Hunt, L. A., Brown, D. W., Robinson, H. L., Naeve, C. W., & Webster, R. G. (1988). Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections. J Virol, 62, 3014-3019.
• Jackwood, M. W. (1999). Current and Future Recombinant Viral Vaccines for Poultry. In, Dodds WJ, Schultz RD, Editors. Veterinary Vaccines and Diagnostics. Cilt 41. San Diego, ABD: Academic Press; 1999, pp. 518-519.
• Jafari, A., Danesh Pouya, F., Niknam, Z., Abdollahpour-Alitappeh, M., Rezaei-Tavirani, M. & Rasmi, Y. (2022). Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms. Mol Biol Rep, 49, 4943–4957.
• Kalhoroa, N. H., Veits, J., Rautenschlein, S. & Zimmer, G. (2009). A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1). Vaccine, 27, 1174–1183.
• Kashoma, I. P., Srivastava, V. & Rajasheka, G. (2019). Advances in Vaccines for Controlling Campylobacter in Poultry. In, Venkitanarayanan K , Thakur S, Ricke SC. Editors. Food Safety in Poultry Meat Production. Cham, İsviçre: Springer Nature Switzerland; 2019, pp. 191-210.
• Kim, S. H., Paldurai, A. & Samal, S. K. (2017). A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus. Virology, 503, 31-36.
• Layton, S. L., Morgan, M. J., Cole, K., Kwon, Y. M., Donoghue, D. J., Hargis, B. M. & Pumford, N. R. (2011). Evaluation of Salmonella-Vectored Campylobacter Peptide Epitopes for Reduction of Campylobacter jejuni in Broiler Chickens. Clin Vaccine Immunol, 18, 449–454.
• Li, K., Gao, L., Gao, H., Qi, X., Gao, Y., Qin, L., Wang, Y. & Wang, X. (2014). Recombinant infectious bursal disease virus expressing Newcastle disease virus (NDV) neutralizing epitope confers partial protection against virulent NDV challenge in chickens. Antiviral Res, 101, 1-11.
• Li, Y., Reddy, K., Reid, S. M., Cox, W. J., Brown, I. H., Britton, P., Nair, V. & Iqbal, M. (2011). Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek’s disease. Vaccine, 29, 8257– 8266.
• Liu, J., Xue, L., Hu, S., Cheng, H., Deng, Y., Hu, Z., Wang, X. & Liu, X. (2018). Chimeric Newcastle disease virus-vectored vaccine protects chickens against H9N2 avian influenza virus in the presence of pre-existing NDV immunity. Arch Virol, 163, 3365-3371.
• Lupini, C., Cecchinato, M., Ricchizzi, E., Naylor, C. J. & Catelli, E. (2011). Turkey rhinotracheitis outbreak caused by the environmental spread of a vaccine derived avian metapneumovirus. Avian Pathol, 40, 525-530. Lütticken, D., Segers, R. P. & Visser, N. (2007). Veterinary vaccines for public health and prevention of viral and bacterial zoonotic diseases. Rev Sci Tech, 26, 165–177.
• Morrison, T., Hinshaw, V. S., Sheerar, M., Cooley, A. J., Brown, D., Mcquain, C. & Mcginnes, L. (1990). Retroviral expressed hemagglutinin-neuraminidase protein protects chickens from Newcastle disease virus induced disease. Microb Pathog, 9, 387-396.
• Moss, B. (2013). Poxvirus DNA Replication. Cold Spring Harb Perspect Biol, 5, a010199.
• Niewiesk, S. (2014). Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol, 5, 446.
• Prandini, F., Simon, B., Jung, A., Pöppel, M., Lemiere, S. & Rautenschlein, S. (2016). Comparison of infectious bursal disease live vaccines and a HVT-IBD vector vaccine and their effects on the immune system of commercial layer pullets. Avian Pathol, 45, 114–125.
• Rajasekaran, R., Kirubaharan, J. J. & Vidhya, M. (2018). Recombinant Veterinary Vaccines. Indian Farmer, 5, 507-513.
• Romanutti, C., Keller, L. & Zanetti, F. A. (2020). Current status of virus-vectored vaccines against pathogens that affect poultry. Vaccine, 38, 6990–7001.
• Shams, H. (2005). Recent developments in veterinary vaccinology. Vet J, 170, 289–299.
• Skinner, M. A., Laidlaw, S. M. & Elda, I. (2005). Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry. Expert Rev Vaccines, 4, 63-76.
• Sonoda, K., Sakaguchi, M., Okamura, H., Yokogawa, K., Tokunaga, E., Tokiyoshi, S., Kawaguchi, Y. & Hirai, K. (2000). Development of an effective polyvalent vaccine against both Marek’s and Newcastle diseases based on recombinant Marek’s disease virus type 1 in commercial chickens with maternal antibodies. J Virol, 74, 3217–3226.
• Tizard, I. R. (2020). Vaccines for Veterinarians. St. Louis, Missouri, ABD: Elsevier.
• Tong, G. Z., Zhang, S. J., Meng, S. S., Wang, L., Qiu, H. J., Wang, Y. F. & Wang, M. (2001). Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus. Avian Pathol, 30, 143–148.
• Toro, H., Zhao, W., Breedlove , C., Zhang, Z., Van Santen, V. & Yu, Q. (2014). Infectious Bronchitis Virus S2 Expressed from Recombinant Virus Confers Broad Protection Against Challenge. Avian Dis, 58, 83-89.
• Van Hulten, M. C. W., Cruz-Coy, J., Gergen, L., Pouwels, H., Ten Dam, G. B., Verstegen, I., de Groof, A., Morsey, M. & Tarpey, I. (2021). Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek’s disease viruses. Avian Pathol, 50, 18–30.
• Wyszyńska, A., Raczko, A., Lis, M. & Jagusztyn-Krynicka, E. K. (2004). Oral immunization of chickens with avirulent Salmonella vaccine strain carrying C. jejuni 72Dz/92 cjaA gene elicits specific humoral immune response associated with protection against challenge with wild-type Campylobacter. Vaccine, 22, 1379-1389.
• Yamanouchi, K., Barrett, T. & Kai, C. (1998). New approaches to the development of virus vaccines for veterinary use. Rev Sci Tech off Int Epiz, 17, 641-653.